Ollin Biosciences
Austin
About Ollin Biosciences
Ollin Biosciences operates as a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 11 – 50
- Total funding: $100.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: ollin.bio
Industries & Categories
Biopharma, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ollin-biosciences-50125 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.